Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Ageing Research Reviews,
Journal Year:
2025,
Volume and Issue:
unknown, P. 102689 - 102689
Published: Feb. 1, 2025
Language: Английский
Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2244 - 2244
Published: July 12, 2024
Aging
is
the
most
prominent
risk
factor
for
neurodegeneration
occurrence.
The
common
neurodegenerative
diseases
(NDs),
Alzheimer’s
(AD)
and
Parkinson’s
(PD)
diseases,
are
characterized
by
incidence
of
proteinopathy,
abnormal
activation
glial
cells,
oxidative
stress,
neuroinflammation,
impaired
autophagy
cellular
senescence
excessive
patient’s
age.
Moreover,
mitochondrial
disfunction,
epigenetic
alterations
neurogenesis
inhibition,
together
with
increased
blood–brain
barrier
permeability
gut
dysbiosis,
have
been
linked
to
ND
pathogenesis.
Since
NDs
still
lack
curative
treatment,
recent
research
has
sought
therapeutic
options
in
restoring
microbiota
supplementing
probiotic
bacteria-derived
metabolites
beneficial
action
host—so
called
postbiotics.
current
review
focuses
on
literature
explaining
mechanisms
involved
pathogenesis
addressing
impact
that
postbiotics
as
a
whole
mixture
particular
metabolites,
such
short-chain
fatty
acids
(SCFAs),
lactate,
polyamines,
polyphenols,
tryptophan
exopolysaccharides
bacterial
extracellular
vesicles,
ageing-associated
processes
underlying
also
discusses
issue
implementing
into
prophylaxis
therapy,
depicting
them
compounds
senescence-triggered
dysfunctions
worth
translating
from
bench
pharmaceutical
market
response
“silver
consumers”
demands.
Language: Английский
Oral Tributyrin Treatment affects Short-Chain Fatty Acid Transport, Mucosal Health, and Microbiome in a Mouse Model of Inflammatory Diarrhea
Zhenghao Ye,
No information about this author
Archana Kini,
No information about this author
Qinghai Tan
No information about this author
et al.
The Journal of Nutritional Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 109847 - 109847
Published: Jan. 1, 2025
Language: Английский
Neuro-nutraceuticals: Emerging molecular and functional insights into how natural products improve brain health
Neurochemistry International,
Journal Year:
2025,
Volume and Issue:
unknown, P. 105948 - 105948
Published: Feb. 1, 2025
Language: Английский
Beneficial Effects of Butyrate on Kidney Disease
Tram N. Diep,
No information about this author
Haoxin Liu,
No information about this author
Liang‐Jun Yan
No information about this author
et al.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(5), P. 772 - 772
Published: Feb. 22, 2025
The
gut
microbiota
influences
and
contributes
to
kidney
health
disease.
Butyrate,
a
short-chain
fatty
acid
molecule
generated
via
the
fermentation
of
bacterial
catabolism
nondigestible
dietary
fiber,
has
been
shown
exert
numerous
beneficial
effects
on
disorders.
objective
this
review
was
discuss
latest
findings
protective
butyrate
variety
animal
models
injury.
We
conducted
PubMed
search
using
title
word
"butyrate"
keyword
"kidney"
generate
our
literature
sources.
covered
in
include
ischemia-reperfusion
renal
injury,
cisplatin-
folic
acid-induced
septic
diabetic
disease
(DKD),
high-fat
diet
(HFD)-induced
glomerulopathy,
adenine-induced
chronic
(CKD),
high-salt-induced
T-2
toxin-induced
injury
birds.
mechanisms
that
are
most
shared
among
these
model
studies
antioxidative
stress,
anti-fibrosis,
anti-inflammation,
anti-cell
death.
This
ends
with
suggestions
for
future
potential
approaches
may
modulate
production
well-being
kidneys
disorders
review.
Language: Английский
Disruption in the human microbiome causing behavioural changes in bipolar disorder
International review of neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Intervention in gut microbiota increases intestinal γ-aminobutyric acid and alleviates anxiety behavior: a possible mechanism via the action on intestinal epithelial cells
Mion Ikegami,
No information about this author
Hikari Narabayashi,
No information about this author
Kazuaki Nakata
No information about this author
et al.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Sept. 5, 2024
The
role
of
the
gut
microbiota
in
gut-brain
axis
has
attracted
attention
recent
years.
Some
produces
γ-aminobutyric
acid
(GABA),
a
major
inhibitory
neurotransmitter
mammals,
Language: Английский